Piramal Pharma Limited Announces Q1 FY27 Financial Results

MUMBAI, India – Piramal Pharma Limited today announced its financial results for the first quarter (Q1 FY27) ended June 30, 2026. The company disclosed both its standalone and consolidated financial outcomes for the period.

The reporting covers the company's performance across all its operations for the specified quarter. Further details regarding the financial statements are expected to be released subsequently.

Piramal Pharma Limited operates as a global pharmaceutical, health, and wellness company. Its shares are traded on the Indian stock exchanges under the tickers NSE: PPLPHARMA and BSE: 543635.

The company is involved in various aspects of the pharmaceutical sector, including drug development and manufacturing. Its activities contribute to its standing within the global healthcare industry.